Home

Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Sell · Filed 25/09/16

Trade details

Type
Insider sale
Amount
$3,319,816.72
Shares · price
27,907 sh · $118.96 a share
Held after
7,229 sh
Trade date
25/09/12
Filed
25/09/16
Days to filing
4 days

Sold 79.4% of holdings

Share of holding sold
79.4%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/13~25/10/12

Herriot Tabuteau's recent trades

  • Herriot Tabuteau

    Planned sale10b5-1 planAxsome Therapeutics

    $979.2K

    Filed 08/06

  • Herriot Tabuteau

    Planned sale10b5-1 planAxsome Therapeutics

    $9.6M

    Filed 08/05

  • Herriot Tabuteau

    Planned sale10b5-1 planAxsome Therapeutics

    $12M

    Filed 07/01

  • Herriot Tabuteau

    Planned sale10b5-1 planAxsome Therapeutics

    $12.2M

    Filed 06/09

  • Herriot Tabuteau

    Sell10b5-1 planAxsome Therapeutics

    $12M

    Filed 06/09

Herriot Tabuteau, CEO — sold $3.3M of Axsome Therapeutics AXSM · 79.4% of holdings · 10b5-1 plan | Whalegun